Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

BPMC Blueprint Medicines Corporation

90,20

0,66 (0,74%)

Vor Marktöffnung

Zuletzt aktualisiert: 13:55:47

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Blueprint Medicines (NASDAQ:BPMC)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Blueprint Medicines Charts.

Blueprint Medicines (NASDAQ:BPMC)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Blueprint Medicines Charts.

News Blueprint Medicines Corporation

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 20 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 20 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Donnerstag 19 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 18 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Blueprint Medicines to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Mittwoch 18 Dezember 2024 (3 Wochen vor) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 17 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Donnerstag 12 Dezember 2024 (4 Wochen vor) • Edgar (US Regulatory)

Blueprint Medicines' Continued Leadership in Redefining the Standard of Care in Systemic Mastocytosis Highlighted at 2024 ASH Annual Meeting
Samstag 7 Dezember 2024 (1 Monat vor) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 3 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 3 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Freitag 29 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Donnerstag 28 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Weitere Blueprint Medicines Corporation News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen